Global Sickle Cell Anemia Drug Sales Market Report 2016

November 2016 | 108 pages | ID: GC9DAF5E4D4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Sickle Cell Anemia Drug

Revenue, means the sales value of Sickle Cell Anemia Drug

This report studies sales (consumption) of Sickle Cell Anemia Drug in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• GlycoMimetics
• Bluebird bio
• GlaxoSmithKline
• Mast Therapeutics
• Bayer AG
• Eli Lilly
• Regen biopharma

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sickle Cell Anemia Drug in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Sickle Cell Anemia Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Sickle Cell Anemia Drug Sales Market Report 2016

1 SICKLE CELL ANEMIA DRUG OVERVIEW

1.1 Product Overview and Scope of Sickle Cell Anemia Drug
1.2 Classification of Sickle Cell Anemia Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Sickle Cell Anemia Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Sickle Cell Anemia Drug Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Sickle Cell Anemia Drug (2011-2021)
  1.5.1 Global Sickle Cell Anemia Drug Sales and Growth Rate (2011-2021)
  1.5.2 Global Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL SICKLE CELL ANEMIA DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Sickle Cell Anemia Drug Market Competition by Manufacturers
  2.1.1 Global Sickle Cell Anemia Drug Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Sickle Cell Anemia Drug Revenue and Share by Manufacturers (2011-2016)
2.2 Global Sickle Cell Anemia Drug (Volume and Value) by Type
  2.2.1 Global Sickle Cell Anemia Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Global Sickle Cell Anemia Drug Revenue and Market Share by Type (2011-2016)
2.3 Global Sickle Cell Anemia Drug (Volume and Value) by Regions
  2.3.1 Global Sickle Cell Anemia Drug Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Sickle Cell Anemia Drug Revenue and Market Share by Regions (2011-2016)
2.4 Global Sickle Cell Anemia Drug (Volume) by Application

3 UNITED STATES SICKLE CELL ANEMIA DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Sickle Cell Anemia Drug Sales and Value (2011-2016)
  3.1.1 United States Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
  3.1.2 United States Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
  3.1.3 United States Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
3.2 United States Sickle Cell Anemia Drug Sales and Market Share by Manufacturers
3.3 United States Sickle Cell Anemia Drug Sales and Market Share by Type
3.4 United States Sickle Cell Anemia Drug Sales and Market Share by Application

4 CHINA SICKLE CELL ANEMIA DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 China Sickle Cell Anemia Drug Sales and Value (2011-2016)
  4.1.1 China Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
  4.1.2 China Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
  4.1.3 China Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
4.2 China Sickle Cell Anemia Drug Sales and Market Share by Manufacturers
4.3 China Sickle Cell Anemia Drug Sales and Market Share by Type
4.4 China Sickle Cell Anemia Drug Sales and Market Share by Application

5 EUROPE SICKLE CELL ANEMIA DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Sickle Cell Anemia Drug Sales and Value (2011-2016)
  5.1.1 Europe Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
  5.1.2 Europe Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
5.2 Europe Sickle Cell Anemia Drug Sales and Market Share by Manufacturers
5.3 Europe Sickle Cell Anemia Drug Sales and Market Share by Type
5.4 Europe Sickle Cell Anemia Drug Sales and Market Share by Application

6 JAPAN SICKLE CELL ANEMIA DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Sickle Cell Anemia Drug Sales and Value (2011-2016)
  6.1.1 Japan Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
  6.1.2 Japan Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
6.2 Japan Sickle Cell Anemia Drug Sales and Market Share by Manufacturers
6.3 Japan Sickle Cell Anemia Drug Sales and Market Share by Type
6.4 Japan Sickle Cell Anemia Drug Sales and Market Share by Application

7 GLOBAL SICKLE CELL ANEMIA DRUG MANUFACTURERS ANALYSIS

7.1 GlycoMimetics
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 GlycoMimetics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Bluebird bio
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 108 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Bluebird bio Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 127 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 GlaxoSmithKline Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Mast Therapeutics
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Mast Therapeutics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Bayer AG
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bayer AG Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Eli Lilly
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Eli Lilly Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Regen biopharma
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Regen biopharma Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview

8 SICKLE CELL ANEMIA DRUG MAUFACTURING COST ANALYSIS

8.1 Sickle Cell Anemia Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Sickle Cell Anemia Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Sickle Cell Anemia Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Sickle Cell Anemia Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL SICKLE CELL ANEMIA DRUG MARKET FORECAST (2016-2021)

12.1 Global Sickle Cell Anemia Drug Sales, Revenue Forecast (2016-2021)
12.2 Global Sickle Cell Anemia Drug Sales Forecast by Regions (2016-2021)
12.3 Global Sickle Cell Anemia Drug Sales Forecast by Type (2016-2021)
12.4 Global Sickle Cell Anemia Drug Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sickle Cell Anemia Drug
Table Classification of Sickle Cell Anemia Drug
Figure Global Sales Market Share of Sickle Cell Anemia Drug by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Sickle Cell Anemia Drug
Figure Global Sales Market Share of Sickle Cell Anemia Drug by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)
Figure China Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)
Figure Europe Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)
Figure Japan Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)
Figure Global Sickle Cell Anemia Drug Sales and Growth Rate (2011-2021)
Figure Global Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)
Table Global Sickle Cell Anemia Drug Sales of Key Manufacturers (2011-2016)
Table Global Sickle Cell Anemia Drug Sales Share by Manufacturers (2011-2016)
Figure 2015 Sickle Cell Anemia Drug Sales Share by Manufacturers
Figure 2016 Sickle Cell Anemia Drug Sales Share by Manufacturers
Table Global Sickle Cell Anemia Drug Revenue by Manufacturers (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Sickle Cell Anemia Drug Revenue Share by Manufacturers
Table 2016 Global Sickle Cell Anemia Drug Revenue Share by Manufacturers
Table Global Sickle Cell Anemia Drug Sales and Market Share by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Sickle Cell Anemia Drug by Type (2011-2016)
Figure Global Sickle Cell Anemia Drug Sales Growth Rate by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue and Market Share by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Sickle Cell Anemia Drug by Type (2011-2016)
Figure Global Sickle Cell Anemia Drug Revenue Growth Rate by Type (2011-2016)
Table Global Sickle Cell Anemia Drug Sales and Market Share by Regions (2011-2016)
Table Global Sickle Cell Anemia Drug Sales Share by Regions (2011-2016)
Figure Sales Market Share of Sickle Cell Anemia Drug by Regions (2011-2016)
Figure Global Sickle Cell Anemia Drug Sales Growth Rate by Regions (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue and Market Share by Regions (2011-2016)
Table Global Sickle Cell Anemia Drug Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Sickle Cell Anemia Drug by Regions (2011-2016)
Figure Global Sickle Cell Anemia Drug Revenue Growth Rate by Regions (2011-2016)
Table Global Sickle Cell Anemia Drug Sales and Market Share by Application (2011-2016)
Table Global Sickle Cell Anemia Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Sickle Cell Anemia Drug by Application (2011-2016)
Figure Global Sickle Cell Anemia Drug Sales Growth Rate by Application (2011-2016)
Figure United States Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
Figure United States Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
Figure United States Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
Table United States Sickle Cell Anemia Drug Sales by Manufacturers (2011-2016)
Table United States Sickle Cell Anemia Drug Market Share by Manufacturers (2011-2016)
Table United States Sickle Cell Anemia Drug Sales by Type (2011-2016)
Table United States Sickle Cell Anemia Drug Market Share by Type (2011-2016)
Table United States Sickle Cell Anemia Drug Sales by Application (2011-2016)
Table United States Sickle Cell Anemia Drug Market Share by Application (2011-2016)
Figure China Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
Figure China Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
Figure China Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
Table China Sickle Cell Anemia Drug Sales by Manufacturers (2011-2016)
Table China Sickle Cell Anemia Drug Market Share by Manufacturers (2011-2016)
Table China Sickle Cell Anemia Drug Sales by Type (2011-2016)
Table China Sickle Cell Anemia Drug Market Share by Type (2011-2016)
Table China Sickle Cell Anemia Drug Sales by Application (2011-2016)
Table China Sickle Cell Anemia Drug Market Share by Application (2011-2016)
Figure Europe Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
Figure Europe Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
Figure Europe Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
Table Europe Sickle Cell Anemia Drug Sales by Manufacturers (2011-2016)
Table Europe Sickle Cell Anemia Drug Market Share by Manufacturers (2011-2016)
Table Europe Sickle Cell Anemia Drug Sales by Type (2011-2016)
Table Europe Sickle Cell Anemia Drug Market Share by Type (2011-2016)
Table Europe Sickle Cell Anemia Drug Sales by Application (2011-2016)
Table Europe Sickle Cell Anemia Drug Market Share by Application (2011-2016)
Figure Japan Sickle Cell Anemia Drug Sales and Growth Rate (2011-2016)
Figure Japan Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2016)
Figure Japan Sickle Cell Anemia Drug Sales Price Trend (2011-2016)
Table Japan Sickle Cell Anemia Drug Sales by Manufacturers (2011-2016)
Table Japan Sickle Cell Anemia Drug Market Share by Manufacturers (2011-2016)
Table Japan Sickle Cell Anemia Drug Sales by Type (2011-2016)
Table Japan Sickle Cell Anemia Drug Market Share by Type (2011-2016)
Table Japan Sickle Cell Anemia Drug Sales by Application (2011-2016)
Table Japan Sickle Cell Anemia Drug Market Share by Application (2011-2016)
Table GlycoMimetics Basic Information List
Table GlycoMimetics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlycoMimetics Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table Bluebird bio Basic Information List
Table Bluebird bio Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bluebird bio Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table Mast Therapeutics Basic Information List
Table Mast Therapeutics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mast Therapeutics Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer AG Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table Regen biopharma Basic Information List
Table Regen biopharma Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Regen biopharma Sickle Cell Anemia Drug Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sickle Cell Anemia Drug
Figure Manufacturing Process Analysis of Sickle Cell Anemia Drug
Figure Sickle Cell Anemia Drug Industrial Chain Analysis
Table Raw Materials Sources of Sickle Cell Anemia Drug Major Manufacturers in 2015
Table Major Buyers of Sickle Cell Anemia Drug
Table Distributors/Traders List
Figure Global Sickle Cell Anemia Drug Sales and Growth Rate Forecast (2016-2021)
Figure Global Sickle Cell Anemia Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Sickle Cell Anemia Drug Sales Forecast by Regions (2016-2021)
Table Global Sickle Cell Anemia Drug Sales Forecast by Type (2016-2021)
Table Global Sickle Cell Anemia Drug Sales Forecast by Application (2016-2021)